Estimating waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics

Hiroaki Murayama, Akira Endo, Shouto Yonekura
doi: https://doi.org/10.1101/2022.07.14.22277647

Article Information

doi 
https://doi.org/10.1101/2022.07.14.22277647
History 
  • July 15, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Hiroaki Murayama1,2,
  2. Akira Endo3,4,5,* and
  3. Shouto Yonekura2
  1. 1School of Medicine, International University of Health and Welfare, Narita, Japan
  2. 2Graduate School of Social Sciences, Chiba University, Chiba, Japan
  3. 3Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
  4. 4Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
  5. 5School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
  1. ↵*Corresponding author: akira.endo{at}lshtm.ac.uk
Back to top
Posted July 15, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Estimating waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics
Hiroaki Murayama, Akira Endo, Shouto Yonekura
medRxiv 2022.07.14.22277647; doi: https://doi.org/10.1101/2022.07.14.22277647
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area